BETRF Projected Dividend Yield
BetterLife Pharma Inc ( OTCBB : BETRF )BetterLife Pharma is a biopharmaceutical company engaged in the development and commercialization of patented, differentiated and quality pharmaceuticals. Co.'s platform technologies include: BETR-001, which is a non-hallucinogenic Lysergic Acid Diethylamide; BETR-002, which is formulation of a derivative of dihydrohonokiol; MM-003, which is a patent pending proprietary recombinant human interferon alpha-2b (IFNa2b) inhalation formulation; MM-001, which is a topical formulation of recombinant human IFNa2b based on the patented Biphasix™ drug formulation technology; and AP-002, which is an organo-gallium complex whose drug substance is tris (8-quinolinolato) gallium(III). 20 YEAR PERFORMANCE RESULTS |
BETRF Dividend History Detail BETRF Dividend News BETRF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |